Andre Collioud

Andre Collioud is a seasoned executive in the biotechnology and pharmaceutical industries with extensive experience in operational and technical leadership. Currently serving as VP and Managing Director at Vaxcyte Switzerland since April 2024, Andre has previously held significant roles, including Site Head at Johnson & Johnson for the Janssen Vaccines site in Bern and various leadership positions at Lonza, Novartis, PaxVax Inc, and Crucell. Notably, Andre has demonstrated expertise in managing large-scale GMP operations, leading biologics supply organizations, and directing manufacturing processes for bacterial vaccines. Andre's educational background includes a PhD in Biochemistry from the University of Bern.